Procedure markets by state
Medicare volume, surgeons and outlook for device-driven procedures, CMS 2024
Where each procedure is used most, where it is growing, how fast it is leaving the hospital and how its surgeons are turning over, in the 51 states MedaRep covers. Built from CMS claims, Medicare Advantage enrollment and Census projections; pick a procedure and a measure, then open a state.
Lumbar fusion by state
Highest: District of Columbia (5.2), Utah (5.1), Colorado (4.6). Lowest: Hawaii (0.9).
Fastest-growing markets since 2019
- Skin substitutes & wound grafts · NV+43%/yr
- CGM & insulin pump management · MS+40%/yr
- Peripheral nerve stimulation & intrathecal pumps · AZ+19%/yr
- SI joint fusion · FL+12%/yr
- Tumor & fibroid embolization · NY+10%/yr
Device procedures with 1,000+ Medicare cases in both years, each at its strongest state; yearly growth in Medicare fee-for-service cases. Reported by CMS. Fee-for-service alone falls as patients move to Medicare Advantage, so its trend understates the market.
Moving out of the hospital fastest
- Tumor & fibroid embolization · TX+61 pts to 63%
- Skin substitutes & wound grafts · WV+55 pts to 82%
- Peripheral nerve stimulation & intrathecal pumps · IN+43 pts to 70%
- Peripheral arterial intervention · NE+43 pts to 62%
- Kyphoplasty & vertebroplasty · TN+34 pts to 60%
Change in the share of surgeons' claims in surgery centers and offices, CMS claim summary.
Most surgeons new to it since 2021
- Debridement & negative-pressure wound therapy · CA505 new
- Skin substitutes & wound grafts · FL237 new
- CGM & insulin pump management · NY215 new
- Breast biopsy & localization · CA70 new
- Superficial venous ablation · CA54 new
Surgeons who started billing the procedure in the state; the ranking names them.
Most turnover ahead, by 2026
- Cholecystectomy & appendectomy · MN17 of 23 (74%)
- Skin substitutes & wound grafts · NC24 of 35 (69%)
- Thrombectomy, IVC filters & venous stents · NY16 of 24 (67%)
- Cervical fusion & disc arthroplasty · NY23 of 35 (66%)
- Carotid revascularization · VA16 of 28 (57%)
Share of today's surgeons with a 50% or better chance of no longer billing it in the state.
Northeast
- Connecticut42 procedures · Advantage 59%Used most above its peers: superficial venous ablation (2.0× per beneficiary)Fastest-growing device market: CGM & insulin pump management (+19%/yr)
- Maine29 procedures · Advantage 62%Used most above its peers: kidney stone management (7.6× per beneficiary)Fastest-growing device market: kidney stone management (+56%/yr)
- Massachusetts50 procedures · Advantage 39%Used most above its peers: kyphoplasty & vertebroplasty (1.6× per beneficiary)Fastest-growing device market: CGM & insulin pump management (+25%/yr)
- New Hampshire36 procedures · Advantage 39%Used most above its peers: radiofrequency ablation (facet, genicular, basivertebral) (1.2× per beneficiary)Fastest-growing device market: CGM & insulin pump management (+35%/yr)
- New Jersey49 procedures · Advantage 45%Used most above its peers: peripheral arterial intervention (1.8× per beneficiary)Fastest-growing device market: skin substitutes & wound grafts (+17%/yr)
- New York52 procedures · Advantage 57%Used most above its peers: tumor & fibroid embolization (1.9× per beneficiary)Fastest-growing device market: CGM & insulin pump management (+16%/yr)
- Pennsylvania51 procedures · Advantage 58%Used most above its peers: spinal cord & DRG stimulation (2.5× per beneficiary)Fastest-growing device market: CGM & insulin pump management (+26%/yr)
- Rhode Island31 procedures · Advantage 66%Used most above its peers: breast biopsy & localization (2.1× per beneficiary)Fastest-growing device market: radiofrequency ablation (facet, genicular, basivertebral) (+15%/yr)
- Vermont20 procedures · Advantage 35%Fastest-growing device market: CGM & insulin pump management (+68%/yr)
Midwest
- Illinois52 procedures · Advantage 47%Used most above its peers: superficial venous ablation (2.0× per beneficiary)Fastest-growing device market: CGM & insulin pump management (+22%/yr)
- Indiana50 procedures · Advantage 53%Used most above its peers: kidney stone management (1.4× per beneficiary)Fastest-growing device market: CGM & insulin pump management (+22%/yr)
- Iowa46 procedures · Advantage 40%Fastest-growing device market: CGM & insulin pump management (+30%/yr)
- Kansas49 procedures · Advantage 36%Used most above its peers: skin substitutes & wound grafts (2.2× per beneficiary)Fastest-growing device market: CGM & insulin pump management (+33%/yr)
- Michigan49 procedures · Advantage 66%Used most above its peers: dialysis access (1.7× per beneficiary)Fastest-growing device market: CGM & insulin pump management (+13%/yr)
- Minnesota48 procedures · Advantage 64%Used most above its peers: prostatectomy & nephrectomy (1.4× per beneficiary)Fastest-growing device market: CGM & insulin pump management (+19%/yr)
- Missouri51 procedures · Advantage 57%Used most above its peers: tumor & fibroid embolization (1.8× per beneficiary)Fastest-growing device market: CGM & insulin pump management (+29%/yr)
- Nebraska40 procedures · Advantage 37%Used most above its peers: incontinence, prolapse & sacral neuromodulation (1.5× per beneficiary)Fastest-growing device market: CGM & insulin pump management (+36%/yr)
- North Dakota30 procedures · Advantage 37%Used most above its peers: breast biopsy & localization (1.3× per beneficiary)Fastest-growing device market: CGM & insulin pump management (+24%/yr)
- Ohio51 procedures · Advantage 60%Used most above its peers: ear tubes & middle ear surgery (1.9× per beneficiary)Fastest-growing device market: CGM & insulin pump management (+34%/yr)
- South Dakota39 procedures · Advantage 39%Used most above its peers: peripheral arterial intervention (2.8× per beneficiary)Fastest-growing device market: CGM & insulin pump management (+45%/yr)
- Wisconsin48 procedures · Advantage 61%Used most above its peers: sinus surgery & balloon dilation (1.4× per beneficiary)Fastest-growing device market: CGM & insulin pump management (+33%/yr)
South
- Alabama47 procedures · Advantage 64%Used most above its peers: sinus surgery & balloon dilation (1.4× per beneficiary)Fastest-growing device market: CGM & insulin pump management (+23%/yr)
- Arkansas43 procedures · Advantage 49%Used most above its peers: peripheral nerve stimulation & intrathecal pumps (1.5× per beneficiary)Fastest-growing device market: CGM & insulin pump management (+31%/yr)
- Delaware33 procedures · Advantage 35%Fastest-growing device market: CGM & insulin pump management (+35%/yr)
- District of Columbia32 procedures · Advantage 39%Used most above its peers: breast biopsy & localization (4.6× per beneficiary)Fastest-growing device market: CGM & insulin pump management (+12%/yr)
- Florida52 procedures · Advantage 60%Used most above its peers: debridement & negative-pressure wound therapy (2.3× per beneficiary)Fastest-growing device market: sleep apnea & airway implants (+55%/yr)
- Georgia51 procedures · Advantage 59%Used most above its peers: dialysis access (1.5× per beneficiary)Fastest-growing device market: CGM & insulin pump management (+22%/yr)
- Kentucky48 procedures · Advantage 57%Used most above its peers: carotid revascularization (1.3× per beneficiary)Fastest-growing device market: CGM & insulin pump management (+26%/yr)
- Louisiana49 procedures · Advantage 60%Used most above its peers: radiofrequency ablation (facet, genicular, basivertebral) (1.5× per beneficiary)Fastest-growing device market: CGM & insulin pump management (+25%/yr)
- Maryland50 procedures · Advantage 28%Used most above its peers: peripheral arterial intervention (1.2× per beneficiary)Fastest-growing device market: CGM & insulin pump management (+30%/yr)
- Mississippi45 procedures · Advantage 46%Used most above its peers: skin substitutes & wound grafts (1.4× per beneficiary)Fastest-growing device market: CGM & insulin pump management (+40%/yr)
- North Carolina51 procedures · Advantage 59%Used most above its peers: tumor & fibroid embolization (1.5× per beneficiary)Fastest-growing device market: CGM & insulin pump management (+18%/yr)
- Oklahoma47 procedures · Advantage 44%Used most above its peers: kyphoplasty & vertebroplasty (1.6× per beneficiary)Fastest-growing device market: CGM & insulin pump management (+33%/yr)
- South Carolina50 procedures · Advantage 48%Used most above its peers: kidney stone management (1.2× per beneficiary)Fastest-growing device market: CGM & insulin pump management (+27%/yr)
- Tennessee51 procedures · Advantage 57%Used most above its peers: kidney stone management (1.3× per beneficiary)Fastest-growing device market: CGM & insulin pump management (+27%/yr)
- Texas52 procedures · Advantage 59%Used most above its peers: superficial venous ablation (1.9× per beneficiary)Fastest-growing device market: sleep apnea & airway implants (+24%/yr)
- Virginia51 procedures · Advantage 42%Used most above its peers: tumor & fibroid embolization (1.6× per beneficiary)Fastest-growing device market: CGM & insulin pump management (+32%/yr)
- West Virginia35 procedures · Advantage 58%Used most above its peers: hysterectomy, hysteroscopy & ablation (1.2× per beneficiary)Fastest-growing device market: CGM & insulin pump management (+28%/yr)
West
- Alaska28 procedures · Advantage 3%Fastest-growing device market: CGM & insulin pump management (+38%/yr)
- Arizona52 procedures · Advantage 54%Used most above its peers: radiofrequency ablation (facet, genicular, basivertebral) (2.7× per beneficiary)Fastest-growing device market: CGM & insulin pump management (+31%/yr)
- California52 procedures · Advantage 56%Used most above its peers: peripheral arterial intervention (2.0× per beneficiary)Fastest-growing device market: skin substitutes & wound grafts (+22%/yr)
- Colorado49 procedures · Advantage 57%Used most above its peers: cervical fusion & disc arthroplasty (1.9× per beneficiary)Fastest-growing device market: CGM & insulin pump management (+29%/yr)
- Hawaii24 procedures · Advantage 62%Fastest-growing device market: CGM & insulin pump management (+42%/yr)
- Idaho38 procedures · Advantage 52%Used most above its peers: lumbar fusion (1.5× per beneficiary)Fastest-growing device market: CGM & insulin pump management (+37%/yr)
- Montana35 procedures · Advantage 32%Used most above its peers: CGM & insulin pump management (1.3× per beneficiary)Fastest-growing device market: CGM & insulin pump management (+30%/yr)
- Nevada41 procedures · Advantage 56%Used most above its peers: skin substitutes & wound grafts (2.2× per beneficiary)Fastest-growing device market: skin substitutes & wound grafts (+43%/yr)
- New Mexico34 procedures · Advantage 54%Fastest-growing device market: CGM & insulin pump management (+18%/yr)
- Oregon47 procedures · Advantage 59%Used most above its peers: prostatectomy & nephrectomy (1.3× per beneficiary)Fastest-growing device market: CGM & insulin pump management (+25%/yr)
- Utah42 procedures · Advantage 57%Used most above its peers: radiofrequency ablation (facet, genicular, basivertebral) (3.0× per beneficiary)Fastest-growing device market: CGM & insulin pump management (+36%/yr)
- Washington50 procedures · Advantage 54%Used most above its peers: breast biopsy & localization (1.2× per beneficiary)Fastest-growing device market: CGM & insulin pump management (+14%/yr)
- Wyoming23 procedures · Advantage 20%Fastest-growing device market: debridement & negative-pressure wound therapy (−0.4%/yr)